Article ID Journal Published Year Pages File Type
8952436 Ophthalmology 2018 10 Pages PDF
Abstract
As a proof of concept, our results suggest that the ablate-and-replace strategy can ameliorate disease progression as measured by photoreceptor structure and function for both of the human mutation knock-in models. These results demonstrate the potency of the ablate-and-replace strategy to treat RP caused by different Rho mutations. Furthermore, because ablate-and-replace treatment is mutation independent, this strategy may be used to treat a wide array of dominant diseases in ophthalmology and other fields. Clinical trials using ablate-and-replace gene therapy would allow researchers to determine if this strategy provides any benefits for patients with diseases of interest.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , , , , , , , , , , , , ,